<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82995">
  <stage>Registered</stage>
  <submitdate>19/07/2008</submitdate>
  <approvaldate>9/12/2009</approvaldate>
  <actrnumber>ACTRN12609001052224</actrnumber>
  <trial_identification>
    <studytitle>Screening for and treatment of asymptomatic candidiasis to prevent preterm birth: A pilot study</studytitle>
    <scientifictitle>In pregnant women with asymptomatic candidiasis does treatment with clotrimozole compared with no treatment reduce the incidence of preterm birth?</scientifictitle>
    <utrn />
    <trialacronym>CiPS</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Preterm birth</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Clotrimazole 100mg pessaries for 6 days. This change was made prior to commencement of the pilot study. Amendment to protocol submitted and approved by HREC.</interventions>
    <comparator>No treatment
This is a 2-arm trial</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Preterm birth less than 37 weeks</outcome>
      <timepoint>At birth</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Admission to Neonatal Intensive Care Unit</outcome>
      <timepoint>Up to first 28 days of life</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Asymptomatic candidiasis
Singleton Pregnancy
Before 20 weeks gestation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Multiple Pregnancy, 
Symptomatic vaginal infection</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>In the pilot study, a research midwife will ask women to participate in the study, explain the trial and obtain informed consent. Women who provide consent will self collect a vaginal swab which will be cultured for candida. Those women who have candida isolated from their vaginal swab will be allocated to treatment or no treatment by central telephone randomisation. The randomisation schedule will be prepared by a researcher not involved with treatment allocation, and will use an equal allocation ratio in blocks of ten. Allocation will be via sealed opaque envelopes. Women randomised to the treatment arm will either return to collect their allocated study treatment from the hospital pharmacy or it will be sent by mail, whichever is more convenient.</concealment>
    <sequence>The randomisation schedule will be prepared by a researcher not involved with treatment allocation, using a computer random number generator.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>12/06/2008</anticipatedstartdate>
    <actualstartdate>12/06/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>18/12/2009</actualenddate>
    <samplesize>500</samplesize>
    <actualsamplesize>500</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>30/06/2010</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Royal North Shore Hospital - St Leonards</hospital>
    <postcode>2065 - St Leonards</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal North Shore Hospital</primarysponsorname>
    <primarysponsoraddress>St Leonards
NSW 2065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal North Shore Hospital</fundingname>
      <fundingaddress>St Leonards
NSW 2065</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a pilot study to assess the fesaibility of a larger study aimed at answering the clinical question: 'In pregnant women with asymptomatic candidiasis does treatment reduce the incidence of preterm birth?'</summary>
    <trialwebsite />
    <publication>Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an openlabel pilot randomized controlled trial
Christine L Roberts*, Kristen Rickard, George Kotsiou, Jonathan M Morris
Roberts et al. BMC Pregnancy and Childbirth 2011, 11:18
http://www.biomedcentral.com/1471-2393/11/18</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Sydney and Central Coast Health (NSCCH)</ethicname>
      <ethicaddress>Royal North Shore Hospital
St Leonards
NSW 2065</ethicaddress>
      <ethicapprovaldate>29/05/2008</ethicapprovaldate>
      <hrec>0708-162M</hrec>
      <ethicsubmitdate>1/06/2007</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Jonathan Morris</name>
      <address>Dept Obstetrics and Gynaecology
Royal North shore Hospital
Building 52
St Leonards NSW 2065</address>
      <phone>+61 2 9926 7013</phone>
      <fax>+61 2 9906 6742</fax>
      <email>jmorris@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jonathan Morris</name>
      <address>Dept Obstetrics and Gynaecology
Royal North shore Hospital
Building 52
St Leonards NSW 2065</address>
      <phone>+61 2 9926 7013</phone>
      <fax>+61 2 9906 6742</fax>
      <email>jmorris@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jonathan Morris</name>
      <address>Dept Obstetrics and Gynaecology
Royal North shore Hospital
Building 52
St Leonards NSW 2065</address>
      <phone>+61 2 9926 7013</phone>
      <fax>+61 2 9906 6742</fax>
      <email>jmorris@med.usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jonathan Morris</name>
      <address>Level 13 Kolling Building, Royal North Shore Hospital, St Leoanrds NSW 2065</address>
      <phone>+61 2 99264731</phone>
      <fax />
      <email>jonathan.morris@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>